Literature DB >> 22349239

Tumor suppressor BLU enhances pro-apoptotic activity of sMEK1 through physical interaction.

Seung Myung Dong1, Hyun-Jung Byun, Boh-Ram Kim, Seung-Hoon Lee, Barry Trink, Seung Bae Rho.   

Abstract

BLU is a tumor suppressor that acts as a transcriptional regulator through the association with cellular components. However, the working mechanism of BLU in cellular functions was not understood. We found that BLU directly interacts with sMEK1, a regulatory subunit of protein phosphatase 4. Furthermore, we determined the binding domains that are required for interaction between BLU and sMEK1. The N-terminal of BLU was observed to interact with the C-terminal of sMEK1. Binding activity was confirmed by the BLU-dependent increase of sMEK1 expression, as well as by the induced apoptotic activity. Also, expression of BLU and sMEK1 was down-regulated in ovarian and cervical patients, and was hypermethylated. These findings indicate that BLU can mediate the pro-apoptotic activity through the induction of sMEK1.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22349239     DOI: 10.1016/j.cellsig.2012.02.002

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  6 in total

1.  Snail Promotes Cancer Cell Proliferation via Its Interaction with the BIRC3.

Authors:  Seung Bae Rho; Hyun-Jung Byun; Boh-Ram Kim; Chang Hoon Lee
Journal:  Biomol Ther (Seoul)       Date:  2022-06-17       Impact factor: 4.231

2.  Ppp4r3a deficiency leads to depression-like behaviors in mice by modulating the synthesis of synaptic proteins.

Authors:  Fei Gao; Ai Liu; Xing Qi; Meitian Wang; Xiao Chen; Shijun Wei; Shang Gao; Yueqing Sun; Ping Sun; Xi Li; Wenjie Sun; Jiangxia Li; Qiji Liu
Journal:  Dis Model Mech       Date:  2022-05-20       Impact factor: 5.732

3.  The anti-tumor activator sMEK1 and paclitaxel additively decrease expression of HIF-1α and VEGF via mTORC1-S6K/4E-BP-dependent signaling pathways.

Authors:  Boh-Ram Kim; Kyungsil Yoon; Hyun-Jung Byun; Seung Hee Seo; Seung-Hoon Lee; Seung Bae Rho
Journal:  Oncotarget       Date:  2014-08-15

4.  sMEK1 inhibits endothelial cell proliferation by attenuating VEGFR-2-dependent-Akt/eNOS/HIF-1α signaling pathways.

Authors:  Boh-Ram Kim; Seung Hee Seo; Mi Sun Park; Seung-Hoon Lee; Youngjoo Kwon; Seung Bae Rho
Journal:  Oncotarget       Date:  2015-10-13

5.  ZMYND10, an epigenetically regulated tumor suppressor, exerts tumor-suppressive functions via miR145-5p/NEDD9 axis in breast cancer.

Authors:  Yan Wang; Liangying Dan; Qianqian Li; Lili Li; Lan Zhong; Bianfei Shao; Fang Yu; Sanxiu He; Shaorong Tian; Jin He; Qian Xiao; Thomas C Putti; Xiaoqian He; Yixiao Feng; Yong Lin; Tingxiu Xiang
Journal:  Clin Epigenetics       Date:  2019-12-04       Impact factor: 6.551

6.  A novel pyroptosis-related indicator of immune infiltration features and prognosis in breast cancer.

Authors:  Cheng Wang; Liyong Zhang; Lin Ren; Guozhi Zhang; Andi Wan; Siyi Xiong; Hao Tian; Zaihui Peng; Tingting Zhao; Pingping Gao; Na Sun; Yi Zhang; Xiaowei Qi
Journal:  Front Oncol       Date:  2022-09-07       Impact factor: 5.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.